Strain Data Sheet

RBRC06344

Strain Information

Image
BRC No.RBRC06344
TypeTargeted MutationCartagena
SpeciesMus musculus
Strain nameC57BL/6-App<tm3(NL-G-F)Tcs>
Former Common nameAPP<NL-G-F>, B6-App/NL-G-F KI
H-2 Haplotype
ES Cell lineiTL IC1 [C57BL/6NTac]
Background strain
Appearance
Strain development理化学研究所脳科学総合研究センター・齋藤貴志先生、西道隆臣先生(2009)。C57BL/6由来ES細胞を用いて作出。NeoカセットはEIIa-creマウス(B6.FVB-Tg(EIIa-cre)C5379Lmgd/J)との交配により除去。C57BL/6背景。
Strain descriptionマウスApp遺伝子のアミロイドβ領域に遺伝子変異を挿入したノックインマウス。マウスアミロイドβ配列のヒト化に加え、家族性アルツハイマー病変異のSwedish変異単独 (App<NL>ノックイン、RBRC06342) 、Iberian変異との2重変異 (App<NL-F>ノックイン、RBRC06343) 、さらにArctic変異を加えた3重変異 (App<NL-G-F>ノックイン、RBRC06344) を導入。ホモマウスは生存性、繁殖性あり。毒性アミロイドβ種 (Aβ42) の産生比率を高め、若齢からアミロイド班を形成する (App<NL>ノックインマウスは陰性コントロールとして利用) 。App<NL-F>ホモマウスは6ヶ月齢から、App<NL-G-F>ホモマウスは2ヶ月齢から脳内においてアミロイド班が形成される。アミロイド班の形成に伴い、神経炎症およびシナプスの脱落が認められる。さらに、App<NL-F>ホモマウスは18ヶ月齢から、App<NL-G-F>ノックインマウスは6ヶ月齢からY迷路における行動異常が認められる。アルツハイマー病研究において重要なモデルマウス。
Colony maintenanceHomozygote x Homozygote [or Crossing to C57BL/6J(Crl)]
References
Single App knock-in mouse models of Alzheimer's disease.
Takashi Saito, Yukio Matsuba, Naomi Mihira, Jiro Takano, Per Nilsson, Shigeyoshi Itohara, Nobuhisa Iwata, Takaomi C Saido
Nat. Neurosci., 17(5):661-663 (2014). 24728269

Recent Advances in the Modeling of Alzheimer's Disease.
Hiroki Sasaguri, Shoko Hashimoto, Naoto Watamura, Kaori Sato, Risa Takamura, Kenichi Nagata, Satoshi Tsubuki, Toshio Ohshima, Atsushi Yoshiki, Kenya Sato, Wakako Kumita, Erika Sasaki, Shinobu Kitazume, Per Nilsson, Bengt Winblad, Takashi Saito, Nobuhisa Iwata, Takaomi C Saido
Front. Neurosci., 16:807473 (2022). 35431779

Human MAPT knockin mouse models of frontotemporal dementia for the neurodegenerative research community.
Takahiro Morito, Mohan Qi, Naoko Kamano, Hiroki Sasaguri, Sumi Bez, Martha Foiani, Karen Duff, Seico Benner, Toshihiro Endo, Hiroshi Hama, Hiroshi Kurokawa, Atushi Miyawaki, Hiroshi Mizuma, Naruhiko Sahara, Masafumi Shimojo, Makoto Higuchi, Takaomi C Saido, Naoto Watamura
Cell Rep. Methods, 5(4):101024 (2025). 40220760

Health Report

Examination Date / Room / Rack2026-07-27Room:4-BRack:D囮検査
2026-05-11Room:4-BRack:D囮検査
2026-01-19Room:3-ARack:A囮検査
2025-11-10Room:3-ARack:A囮検査
2025-09-01Room:3-ARack:A囮検査
2025-06-16Room:3-ARack:A囮検査
2025-04-07Room:3-ARack:A囮検査
2025-01-07Room:3-ARack:A囮検査

Gene

Gene SymbolGene NameChr.Allele SymbolAllele NameCommon NamesPromoterDiseases Related to This Gene
App
MGI:88059
amyloid beta precursor protein16App<tm3(NL-G-F)Tcs>
MGI:5637817
targeted mutation 3, Takaomi C. Saido
  • Alzheimer disease type 1(MedGEN)

  • Alzheimer disease(DisGeNET)

  • cerebral amyloid angiopathy, APP-related(MedGEN)
  • Frt yeast FRT (flippase recombination target) site16Frt
    loxP phage P1 loxP16loxP

    Phenotype

    Phenotype annotation from literatures by Mammalian phenotype ontology
  • abnormal learning/memory/conditioning (MP:0002063)

  • abnormal synapse morphology (MP:0009538)

  • amyloid beta deposits (MP:0003329)

  • amyloidosis (MP:0000604)

  • astrocytosis (MP:0003354)
  • more 1 phenotypes
  • microgliosis (MP:0008918)
  • Detailed phenotype data

    Ordering Information

    供与核酸phage P1 loxP site, yeast FRT (flipase recombination target) site, mouse App genomic DNA (mutant type)
    Research applicationCre/loxP system
    FLP/frt system
    Mouse Models for Human Disease
    提供条件本件リソースは国立研究開発法人理化学研究所が所有権を有している。研究成果の公表にあたって斉藤貴志博士、西道隆臣博士への謝辞の表明を必要とする。利用者は、本件リソースを利用して得られた全ての論文発表においては、Nature Neuroscience 17, 661-663 (2014)を引用する。利用者は、本件リソースに関わる全ての口頭発表および出版物において、寄託者に謝辞を述べる。利用者は、本件リソースに関して寄託者から提供された「CONFIDENTIAL」と捺印されたいかなる情報も機密としなくてはならない。口頭での議論も、議論がなされた日から30日以内に文書化されて「CONFIDENTIAL」と捺印された場合は、機密情報とする。営利機関はライセンス契約について寄託者に直接問い合わせる(takaomi.saido@riken.jp)。提供MTAの期間内に、本件リソースを用いた研究計画の遂行において、利用者が発明を創出し実用化した場合は、利用者はこの発明について速やかに寄託者に通知しなくてはならない。また、当事者は特許申請を提出する前に、その発明に対する各当事者の貢献に基づいた発明者適格および所有権を決定するために各々と協議することとする。共同所有の出願の場合には、各当事者は、出願手続きに係る責任について、並びに、所有権、特許費用及び特許料収入の共有について、寄託者と共同出願協定を締結することとする。
    Depositor西道 隆臣(独立行政法人理化学研究所)
    Strain Status生体のアイコン生体
    凍結胚のアイコン凍結胚
    凍結精子のアイコン凍結精子
    Strain Availability凍結精子を1ヶ月以内に提供可能
    凍結胚を1ヶ月以内に提供可能
    生体マウスを1~3ヶ月以内に提供可能
    Additional Info.Necessary documents for ordering:
    1. Order form (Japanese / English)
    2. Category I MTA: MTA for distribution with RIKEN BRC (Japanese / English)
    3. Acceptance of responsibility for living modified organism (Japanese / English)
    Lab HP (RIKEN Bio Co., Ltd.
    Genotyping protocol -PCR-
    Mouse of the Month Sep 2014

    BRC mice in Publications

    Kim Y, Lee G, An S, Park H, Kim H, Kim J, Kang S, Kim S, Kwon D, Park J, Hwang Y, Kim S, Yuan X, Jeong J, Lee H, Kim HK, Kim J.
    Therapeutic Gene Editing of APOE4 in Sporadic Alzheimer's Disease via Prime Editor 7.
    Adv Sci (Weinh) e76658(2026) 42467931
    Araki K, Yamauchi K, Ito S, Koike M, Hioki H.
    The difference in immunohistochemical reactivity of monoclonal antibodies against amino-terminal residues of amyloid-β peptide.
    Anat Sci Int (2026) 41505017
    Kim J, Hwang Y, Kim S, Kwon D, Park J, Cho B, An S, Kang S, Kim Y, Kim S, Lengner CJ, Kim S, Kwon Y, Sung JS, Kim J.
    Electromagnetic field-inducible in vivo gene switch for remote spatiotemporal control of gene expression.
    Cell (2026) 41985457
    Ohi Y, Hada K, Murata Y, Kodama D, Wakiya Y.
    Bidirectional effects of orexin receptor antagonists on long-term potentiation in the hippocampus of wild type and Alzheimer's disease model mice.
    J Pharmacol Sci 160(1) 37-40(2026) 41390193
    Li C, Chia XW, Xu G, Ang LF, Makino H.
    Vulnerability of short-term memory in a mouse model of Alzheimer's disease.
    Nat Commun (2026) 41714332
    Nakagawa T, Xie JL, Park K, Cao K, Savadkohighodjanaki M, Zhang YJ, Jun H, Ichii A, Lee JY, Soma S, Medhat YK, Saido TC, Igarashi KM.
    Early dopamine disruption in the entorhinal cortex of a knock-in model of Alzheimer's disease.
    Nat Neurosci 29(6) 1386-1396(2026) 42026254
    Takeda A, Takeuchi T, Minakawa EN, Tanaka N, Mochizuki H, Nagai Y.
    Blood extracellular vesicles contribute to the exercise-mediated suppression of brain Aβ pathology in the AppNL-G-F knockin mouse model of Alzheimer's disease.
    Neurochem Int 106120(2026) 41548697
    Ellingford R, Harris SS, Kehring M, Rajani RM, Lam FKW, Graykowski D, Bӧken D, Welikovitch LA, Khasnavis A, Laban R, Heslegrave A, Yaman U, Mate de Gerando A, Bond SA, Wray S, Salih DA, Dupret D, Dolan RJ, Klenerman D, Zetterberg H, Hyman BT, Busche MA.
    Alzheimer's disease pathology degrades an NMDA receptor-dependent spontaneous activity pattern in cortico-hippocampal circuits.
    Neuron (2026) 41916281
    Akasaka T, Watanabe H, Ono M.
    Novel BODIPY-Based Fluorescent Probes with Improved Aqueous Solubility for Selective Detection of Soluble Aβ Aggregates.
    ACS Chem Neurosci (2025) 41093813
    Krunic A, Bellio TA, Cohen BZ, Labadorf A, Stein TD, Lin H, Mellott TJ, Blusztajn JK.
    Brain DNA Methylation Atlas of AppNL-G-F Alzheimer's Disease Model Mice Across Age and Region Reveals Choline-Induced Resilience.
    Aging Cell 24(11) e70241(2025) 41081550
    Bellio TA, Krunic A, Campion MS, Dupaguntla R, Labadorf A, Stein TD, Lin H, Mellott TJ, Blusztajn JK.
    Perinatal Choline Supplementation Promotes Resilience Against Progression of Alzheimer's Disease-Like Brain Transcriptomic Signatures in AppNL-G-F Mice.
    Aging Cell e70148(2025) 41081549
    Etani H, Takatori S, Wang W, Omi J, Amiya Y, Akahori A, Watanabe H, Sonn I, Okano H, Hara N, Hasegawa M, Miyashita A, Kikuchi M, Ikeuchi T, Morishima M, Saito Y, Murayama S, Saito T, Saido TC, Takai T, Ohwada T, Aoki J, Tomita T.
    Selective agonism of GPR34 stimulates microglial uptake and clearance of amyloid β fibrils.
    Alzheimers Res Ther 17(1) 248(2025) 41261421
    Yamauchi K, Koike M, Hioki H.
    A three dimensional immunolabeling method with peroxidase-fused nanobodies and fluorochromized tyramide-glucose oxidase signal amplification.
    Commun Biol 8(1) 903(2025) 40533487
    Sunao Kawakami, Cha-Gyun Jung, Rieko Inoue, Tomohisa Nakamura, Soh Sato, Makoto Michikawa
    Elevated Flotillin-1 in Saliva and Salivary Glands: A Novel Non-Invasive Biomarker in an Alzheimer’s Disease Mouse Model
    Diagnostics 16 61(2025) 41515556
    Huang ML, Suzuki Y, Sasaguri H, Saito T, Saido TC, Imayoshi I.
    Misclassification in memory modification in AppNL-G-F knock-in mouse model of Alzheimer's disease.
    Elife 14 (2025) 41186287
    Bansal VA, Tan JM, Soon HR, Zainolabidin N, Saido T, Ch'ng TH.
    Aβ-driven nuclear pore complex dysfunction alters activation of necroptosis proteins in a mouse model of Alzheimer's disease.
    Elife 13 (2025) 40132021
    Guo L, Gaunt JR, Cheah CCH, Chen AI, Claudine S, Dawe GS, Goh ELK, Kho SH, Kumar P, Lim GGY, Lim KL, Lim YA, Saido TC, Saito T, Sasaguri H, Sng JCG, Yeap YJ, Yip AKK, Zainolabidin N, Ch'ng TH, Augustine GJ.
    APOE4-APP interactions exert early influences on cerebrovascular structure and function: implications for Alzheimer's disease.
    Front Neurosci 19 1629830(2025) 41211332
    Gui S, Zeng F, Wu Z, Nonaka S, Sano T, Ni J, Nakanishi H, Moriyama M, Kanematsu T.
    Lipopolysaccharides from Porphyromonas gingivalis indirectly induce neuronal GSK3β-dependent synaptic defects and cause cognitive decline in a low-amyloid-β-concentration environment in Alzheimer's disease.
    J Alzheimers Dis 105(1) 302-316(2025) 40111934
    Choi DJ, Murali S, Kwon W, Woo J, Song EC, Ko Y, Sardar D, Lozzi B, Cheng YT, Williamson MR, Huang TW, Sanchez K, Jankowsky J, Deneen B.
    Astrocytic Sox9 overexpression in Alzheimer's disease mouse models promotes Aβ plaque phagocytosis and preserves cognitive function.
    Nat Neurosci (2025) 41272323
    Fujii K, Takeuchi T, Fujino Y, Tanaka N, Fujino N, Takeda A, Minakawa EN, Nagai Y.
    Oral administration of arginine suppresses Aβ pathology in animal models of Alzheimer's disease.
    Neurochem Int 191 106082(2025) 41175945
    Papanikolaou A, Graykowski D, Lee BI, Yang M, Ellingford R, Zünkler J, Bond SA, Rowland JM, Rajani RM, Harris SS, Sharp DJ, Busche MA.
    Selectively vulnerable deep cortical layer 5/6 fast-spiking interneurons in Alzheimer's disease models in vivo.
    Neuron (2025) 40345184
    Maruyama R, Fukumori A, Funamoto S, Okada K, Akamine S, Yanagida K, Shinohara M, Sato N, Okochi M, Kudo T, Steiner H.
    γ-Secretase exosites as targets for substrate-selective lowering of Aβ generation.
    Structure (2025) 41418776
    Nagashima K, Watanabe H, Akasaka T, Ono M.
    Development of Triphenylmethane Dyes for In Vivo Fluorescence Imaging of Aβ Oligomers.
    ACS Chem Neurosci 15(11) 2233-2242(2024) 38753435
    Sasaki K, Fujita H, Sato T, Kato S, Takahashi Y, Takeshita Y, Kanda T, Saito T, Saido TC, Hattori S, Hozumi Y, Yamada Y, Waki H.
    GLP-1 receptor signaling restores aquaporin 4 subcellular polarization in reactive astrocytes and promotes amyloid β clearance in a mouse model of Alzheimer's disease.
    Biochem Biophys Res Commun 741 151016(2024) 39577079
    Huang H, Sharoar MG, Pathoulas J, Fan L, He W, Xiang R, Yan R.
    Accumulation of neutral lipids in dystrophic neurites surrounding amyloid plaques in Alzheimer's disease.
    Biochim Biophys Acta Mol Basis Dis 1870(4) 167086(2024) 38378084
    Miller SR, Luxem K, Lauderdale K, Nambiar P, Honma PS, Ly KK, Bangera S, Bullock M, Shin J, Kaliss N, Qiu Y, Cai C, Shen K, Mallen KD, Yan Z, Mendiola AS, Saito T, Saido TC, Pico AR, Thomas R, Roberson ED, Akassoglou K, Bauer P, Remy S, Palop JJ.
    Machine learning reveals prominent spontaneous behavioral changes and treatment efficacy in humanized and transgenic Alzheimer's disease models.
    Cell Rep 43(11) 114870(2024) 39427315
    Mathys H, Boix CA, Akay LA, Xia Z, Davila-Velderrain J, Ng AP, Jiang X, Abdelhady G, Galani K, Mantero J, Band N, James BT, Babu S, Galiana-Melendez F, Louderback K, Prokopenko D, Tanzi RE, Bennett DA, Tsai LH, Kellis M.
    Single-cell multiregion dissection of Alzheimer's disease.
    Nature 632(8026) 858-868(2024) 39048816
    Abdelhamid M, Jung CG, Zhou C, Inoue R, Chen Y, Sento Y, Hida H, Michikawa M.
    Potential Therapeutic Effects of Bifidobacterium breve MCC1274 on Alzheimer's Disease Pathologies in AppNL-G-F Mice.
    Nutrients 16(4) (2024) 38398861
    Rajani RM, Ellingford R, Hellmuth M, Harris SS, Taso OS, Graykowski D, Lam FKW, Arber C, Fertan E, Danial JSH, Swire M, Lloyd M, Giovannucci TA, Bourdenx M, Klenerman D, Vassar R, Wray S, Sala Frigerio C, Busche MA.
    Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer's disease.
    PLoS Biol 22(7) e3002727(2024) 39042667
    Fukuda M, Okanishi H, Ino D, Ono K, Kawamura S, Wakai E, Miyoshi T, Sato T, Ohta Y, Saito T, Saido TC, Inohara H, Kanai Y, Hibino H.
    Disturbance in the protein landscape of cochlear perilymph in an Alzheimer's disease mouse model.
    PLoS One 19(5) e0303375(2024) 38728348
    Bellio TA, Laguna-Torres JY, Campion MS, Chou J, Yee S, Blusztajn JK, Mellott TJ.
    Perinatal choline supplementation prevents learning and memory deficits and reduces brain amyloid Aβ42 deposition in AppNL-G-F Alzheimer's disease model mice.
    PLoS One 19(2) e0297289(2024) 38315685
    Yamada H, Yamazaki Y, Takebayashi Y, Yazawa K, Sasanishi M, Motoda A, Nakamori M, Morino H, Takahashi T, Maruyama H.
    The long-term effects of heated tobacco product exposure on the central nervous system in a mouse model of prodromal Alzheimer's disease.
    Sci Rep 14(1) 227(2024) 38167640
    AlQot HE, Rylett RJ.
    Primate-specific 82-kDa choline acetyltransferase attenuates progression of Alzheimer's disease-like pathology in the APPNL-G-F knock-in mouse model.
    Sci Rep 14(1) 27614(2024) 39528509
    Takebayashi Y, Yamazaki Y, Yamada H, Yazawa K, Nakamori M, Kurashige T, Morino H, Takahashi T, Sotomaru Y, Maruyama H.
    Apolipoprotein E genotype-dependent accumulation of amyloid β in APP-knock-in mouse model of Alzheimer's disease.
    Biochem Biophys Res Commun 683 149106(2023) 37857162
    Keramidis I, McAllister BB, Bourbonnais J, Wang F, Isabel D, Rezaei E, Sansonetti R, Degagne P, Hamel JP, Nazari M, Inayat S, Dudley JC, Barbeau A, Froux L, Paquet ME, Godin AG, Mohajerani MH, De Koninck Y.
    Restoring neuronal chloride extrusion reverses cognitive decline linked to Alzheimer's disease mutations.
    Brain 146(12) 4903-4915(2023) 37551444
    Ho H, Kejzar N, Sasaguri H, Saito T, Saido TC, De Strooper B, Bauza M, Krupic J.
    A fully automated home cage for long-term continuous phenotyping of mouse cognition and behavior.
    Cell Rep Methods 3(7) 100532(2023) 37533650
    Hata S, Saito H, Kakiuchi T, Fukumoto D, Yamamoto S, Kasuga K, Kimura A, Moteki K, Abe R, Adachi S, Kinoshita S, Yoshizawa-Kumagaye K, Nishio H, Saito T, Saido TC, Yamamoto T, Nishimura M, Taru H, Sobu Y, Ohba H, Nishiyama S, Harada N, Ikeuchi T, Tsukada H, Ouchi Y, Suzuki T.
    Brain p3-Alcβ peptide restores neuronal viability impaired by Alzheimer's amyloid β-peptide.
    EMBO Mol Med 15(5) e17052(2023) 36994913
    Daniels MJD, Lefevre L, Szymkowiak S, Drake A, McCulloch L, Tzioras M, Barrington J, Dando OR, He X, Mohammad M, Sasaguri H, Saito T, Saido TC, Spires-Jones TL, McColl BW.
    Cystatin F (Cst7) drives sex-dependent changes in microglia in an amyloid-driven model of Alzheimer's disease.
    Elife 12 (2023) 38085657
    Yoshida K, Kato D, Sugio S, Takeda I, Wake H.
    Activity-dependent oligodendrocyte calcium dynamics and their changes in Alzheimer's disease.
    Front Cell Neurosci 17 1154196(2023) 38026691
    Kaneko R, Matsui A, Watanabe M, Harada Y, Kanamori M, Awata N, Kawazoe M, Takao T, Kobayashi Y, Kikutake C, Suyama M, Saito T, Saido TC, Ito M.
    Increased neutrophils in inflammatory bowel disease accelerate the accumulation of amyloid plaques in the mouse model of Alzheimer's disease.
    Inflamm Regen 43(1) 20(2023) 36922861
    Tun X, Wang EJ, Gao Z, Lundberg K, Xu R, Hu D.
    Integrin β3-Mediated Cell Senescence Associates with Gut Inflammation and Intestinal Degeneration in Models of Alzheimer's Disease.
    Int J Mol Sci 24(6) (2023) 36982771
    Sahu B, Johnson LM, Sohrabi M, Usatii AA, Craig RMJ, Kaelberer JB, Chandrasekaran SP, Kaur H, Nookala S, Combs CK.
    Effects of Probiotics on Colitis-Induced Exacerbation of Alzheimer's Disease in AppNL-G-F Mice.
    Int J Mol Sci 24(14) (2023) 37511312
    Osman B, Wang Z, Shiraishi K, Yokoyama M and Matsumura Y.
    Precipitation of Insoluble Fibrin in the Brains of Alzheimer’s Disease Model Mice.
    J Blood Disord 10(1) 1070(2023)
    Akasaka T, Watanabe H, Ono M.
    In Vivo Near-Infrared Fluorescence Imaging Selective for Soluble Amyloid β Aggregates Using y-Shaped BODIPY Derivative.
    J Med Chem (2023) 37824378
    Naganuma F, Murata D, Inoue M, Maehori Y, Harada R, Furumoto S, Kudo Y, Nakamura T, Okamura N.
    A Novel Near-Infrared Fluorescence Probe THK-565 Enables In Vivo Detection of Amyloid Deposits in Alzheimer's Disease Mouse Model.
    Mol Imaging Biol 25(6) 1115-1124(2023) 37580462
    Honda K, Saito Y, Saito H, Toyoda M, Abe R, Saito T, Saido TC, Michikawa M, Taru H, Sobu Y, Hata S, Nakaya T, Suzuki T.
    Accumulation of amyloid-β in the brain of mouse models of Alzheimer's disease is modified by altered gene expression in the presence of human apoE isoforms during aging.
    Neurobiol Aging 123 63-74(2023) 36638682
    Kilian JG, Mejias-Ortega M, Hsu HW, Herman DA, Vidal J, Arechavala RJ, Renusch S, Dalal H, Hasen I, Ting A, Rodriguez-Ortiz CJ, Lim SL, Lin X, Vu J, Saito T, Saido TC, Kleinman MT, Kitazawa M.
    Exposure to quasi-ultrafine particulate matter accelerates memory impairment and Alzheimer's disease-like neuropathology in the AppNL-G-F knock-in mouse model.
    Toxicol Sci 193(2) 175-191(2023) 37074955
    Iguchi A, Takatori S, Kimura S, Muneto H, Wang K, Etani H, Ito G, Sato H, Hori Y, Sasaki J, Saito T, Saido TC, Ikezu T, Takai T, Sasaki T, Tomita T.
    INPP5D modulates TREM2 loss-of-function phenotypes in a β-amyloidosis mouse model.
    iScience 26(4) 106375(2023) 37035000
    Shang Y, Sun X, Chen X, Wang Q, Wang EJ, Miller E, Xu R, Pieper AA, Qi X.
    A CHCHD6-APP axis connects amyloid and mitochondrial pathology in Alzheimer's disease.
    Acta Neuropathol 144(5) 911-938(2022) 36104602
    Borcuk C, Héraud C, Herbeaux K, Diringer M, Panzer É, Scuto J, Hashimoto S, Saido TC, Saito T, Goutagny R, Battaglia D, Mathis C.
    Early memory deficits and extensive brain network disorganization in the AppNL-F/MAPT double knock-in mouse model of familial Alzheimer's disease.
    Aging Brain 2 100042(2022) 36908877
    Xie Z, Meng J, Kong W, Wu Z, Lan F, Narengaowa, Hayashi Y, Yang Q, Bai Z, Nakanishi H, Qing H, Ni J.
    Microglial cathepsin E plays a role in neuroinflammation and amyloid β production in Alzheimer's disease.
    Aging Cell 21(3) e13565(2022) 35181976
    Kamei N, Hashimoto A, Tanaka E, Murata K, Yamaguchi M, Yokoyama N, Kato M, Oki K, Saito T, Saido TC, Takeda-Morishita M.
    Therapeutic effects of anti-amyloid β antibody after intravenous injection and efficient nose-to-brain delivery in Alzheimer's disease mouse model.
    Drug Deliv Transl Res 12(11) 2667-2677(2022) 35015254
    Hiroki Sasaguri, Shoko Hashimoto, Naoto Watamura, Kaori Sato, Risa Takamura, Kenichi Nagata, Satoshi Tsubuki, Toshio Ohshima, Atsushi Yoshiki, Kenya Sato, Wakako Kumita, Erika Sasaki, Shinobu Kitazume, Per Nilsson, Bengt Winblad, Takashi Saito, Nobuhisa Iwata, Takaomi C. Saido
    Recent Advances in the Modeling of Alzheimer’s Disease
    Frontiers Neuroscience 16 (2022) 35431779
    Abdelhamid M, Zhou C, Ohno K, Kuhara T, Taslima F, Abdullah M, Jung CG, Michikawa M.
    Probiotic Bifidobacterium breve Prevents Memory Impairment Through the Reduction of Both Amyloid-β Production and Microglia Activation in APP Knock-In Mouse.
    J Alzheimers Dis 85(4) 1555-1571(2022) 34958017
    Murakami A, Hara T, Yamada-Kubota C, Kuwahara M, Ichikawa T, Minagi S.
    Lack of occlusal support did not impact amyloid β deposition in APP knock-in mice.
    J Prosthodont Res 66(1) 161-166(2022) 34305086
    Ye Q, Gast G, Su X, Saito T, Saido TC, Holmes TC, Xu X.
    Hippocampal neural circuit connectivity alterations in an Alzheimer's disease mouse model revealed by monosynaptic rabies virus tracing.
    Neurobiol Dis 172 105820(2022) 35843448
    Park H, Shin J, Kim Y, Saito T, Saido TC, Kim J.
    CRISPR/dCas9-Dnmt3a-mediated targeted DNA methylation of APP rescues brain pathology in a mouse model of Alzheimer's disease.
    Transl Neurodegener 11(1) 41(2022) 36109806
    Gannon M, Wang B, Stringfellow SA, Quintin S, Mendoza I, Srikantha T, Roberts AC, Saito T, Saido TC, Roberson ED, Yacoubian TA.
    14-3-3θ Does Not Protect against Behavioral or Pathological Deficits in Alzheimer's Disease Mouse Models.
    eNeuro 9(3) (2022) 35697511
    Vandenabeele M, Veys L, Lemmens S, Hadoux X, Gelders G, Masin L, Serneels L, Theunis J, Saito T, Saido TC, Jayapala M, De Boever P, De Strooper B, Stalmans I, van Wijngaarden P, Moons L, De Groef L.
    The AppNL-G-F mouse retina is a site for preclinical Alzheimer's disease diagnosis and research.
    Acta Neuropathol Commun 9(1) 6(2021) 33407903
    Tomoyuki Mano, Ken Murata, Kazuhiro Kon, Chika Shimizu, Hiroaki Ono, Shoi Shi, Rikuhiro G. Yamada, Kazunari Miyamichi, Etsuo A. Susaki, Kazushige Touhara, Hiroki R. Ueda
    CUBIC-Cloud provides an integrative computational framework toward community-driven whole-mouse-brain mapping
    Cell Reports Methods 1 100038(2021) 35475238
    Liu X, Zhou Q, Zhang JH, Wang KY, Saito T, Saido TC, Wang X, Gao X, Azuma K.
    Microglia-Based Sex-Biased Neuropathology in Early-Stage Alzheimer's Disease Model Mice and the Potential Pharmacologic Efficacy of Dioscin.
    Cells 10(11) (2021) 34831483
    Sohrabi M, Pecoraro HL, Combs CK.
    Gut Inflammation Induced by Dextran Sulfate Sodium Exacerbates Amyloid-β Plaque Deposition in the AppNL-G-F Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis 79(3) 1235-1255(2021) 33427741
    Minamisawa M, Sato Y, Ishiguro E, Taniai T, Sakamoto T, Kawai G, Saito T, Saido TC.
    Amelioration of Alzheimer's Disease by Gut-Pancreas-Liver-Brain Interaction in an App Knock-In Mouse Model.
    Life (Basel) 12(1) (2021) 35054427
    Xiang X, Wind K, Wiedemann T, Blume T, Shi Y, Briel N, Beyer L, Biechele G, Eckenweber F, Zatcepin A, Lammich S, Ribicic S, Tahirovic S, Willem M, Deussing M, Palleis C, Rauchmann BS, Gildehaus FJ, Lindner S, Spitz C, Franzmeier N, Baumann K, Rominger A, Bartenstein P, Ziegler S, Drzezga A, Respondek G, Buerger K, Perneczky R, Levin J, Höglinger GU, Herms J, Haass C, Brendel M.
    Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases.
    Sci Transl Med 13(615) eabe5640(2021) 34644146
    Narukawa M, Takahashi S, Saito T, Saido TC, Misaka T.
    Analysis of Taste Sensitivities in App Knock-In Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis 76(3) 997-1004(2020) 32568206
    Sacher C, Blume T, Beyer L, Biechele G, Sauerbeck J, Eckenweber F, Deussing M, Focke C, Parhizkar S, Lindner S, Gildehaus FJ, von Ungern-Sternberg B, Baumann K, Tahirovic S, Kleinberger G, Willem M, Haass C, Bartenstein P, Cumming P, Rominger A, Herms J, Brendel M.
    Asymmetry of Fibrillar Plaque Burden in Amyloid Mouse Models.
    J Nucl Med 61(12) 1825-1831(2020) 32414948